12 July 2024 | News
Indegene has instituted the ‘GenAI @ Work’ initiative, where all its 5,000+ employees will be trained on various facets of GenAI
image credit- shutterstock
Indegene has announced a strategic collaboration with Microsoft to empower global life sciences companies to scale up the adoption of purpose-built, enterprise-grade Generative AI (GenAI) services, thereby driving faster innovation at scale.
Indegene and Microsoft have committed to developing resources in highly specialised and skilled medical and technology tools to co-innovate generative AI services and workflows across commercial, medical, regulatory, and clinical functions.
Some of the key use cases the strategic collaboration focuses on in the first phase, include:
To develop a future-ready workforce, Indegene has also instituted the ‘GenAI @ Work’ initiative, where all its 5,000+ employees will be trained on various facets of GenAI to enhance automation and productivity, allowing its employees to focus on higher-value tasks. As part of this initiative, Indegene has deployed Microsoft Copilot in several of its core business processes and has already started seeing significant productivity improvements.